EQUILLIUM, INC. Net Fee Amt
EQUILLIUM, INC. (EQ) had Net Fee Amt of $5.01 thousand as of 2026-04-06, per its S-3 filed 2026-04-07.
Financial Statements › Notes
ffd:NetFeeAmt · last filed 2026-04-07
- 2026-04-06: Net Fee Amt $5.01K.
| Period end | Net Fee Amt |
|---|---|
| 2026-04-06 | $5.01K S-3 · filed 2026-04-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Biomea Fusion, Inc. (BMEA) | United States | $0.107B | -3.30 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |